Eugeniusz Pilat

Eugeniusz Pilat

Auto-generated profile, based on publicly available information

Eugeniusz Pilat

Department of Electrocardiology Upper‐Silesian Medical Centre in Katowice Katowice Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2026 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
MJMichał Joniec
Michał Joniec
JSJoanna Stachanczyk
Joanna Stachanczyk
SGSylwia Gladysz-Wanha
Sylwia Gladysz-Wanha
EPEugeniusz Pilat
Eugeniusz Pilat
ADAnna Drzewiecka
Anna Drzewiecka
KGKrzysztof Stanislaw Golba
Krzysztof Stanislaw Golba
Background: Venous thrombosis occurring after TLE procedures is a fairly common but poorly described complication and requires further investigation into its causes. Aim: The aim of this study was to identify independent predictors of UEDVT occurrence after TLE procedures. Methods: We analyzed data from 504 transvenous lead extraction procedures performed in the hybrid surgery room of the Department of Electrocardiology and Heart Failure at the Medical University of Silesia, Katowice, Poland, between January 2016 and May 2022. All procedures were performed using mechanical‐only techniques. Results: In the analyzed period, as a result of 504 transvenous extraction procedures of cardiac implantable electronic device leads, 19 (3.8%) cases of symptomatic venous thrombosis of the upper extremity on the side of the procedure occurred. The mean age of patients who developed the complication was 65.8 ± 13.3 years, and 68.4% were men, which did not differ significantly from the general group. Based on variables selected in the univariate analysis, a logistic regression model of risk factors for UEDVT was calculated. These include a history of cancer disease in patients ( p = 0.0110), heart failure according to the Class IV NYHA scale ( p = 0.0397), advanced longest dwell time ( p = 0.0323), extraction of atrial lead ( p = 0.0368), and the use of mechanical non‐powered telescopic sheaths ( p = 0.0455). As protective factors were assessed, infectious indications for TLE ( p = 0.0288) and the highest platelet concentration ( p = 0.0448). Conclusions: Thrombosis is a relatively rare but serious complication. The precise selection of patients at risk of thrombosis after TLE may increase clinical success. It has been shown that an increased risk of thrombosis after TLE occurs in patients with a history of cancer, with heart failure in NYHA Class IV, and platelet concentration is low, in whom TLE is performed for noninfectious reasons, with the use of additional equipment like mechanical non‐powered telescopic sheaths.